Veeva Basics: A Game Changer for Emerging Biotechs
In the dynamic landscape of biotechnology,
Veeva Systems has emerged as a critical partner for over
75 biotech companies that are leveraging its Veeva Basics software suite. Designed for companies aiming for rapid growth, Veeva Basics offers tailored tools that optimize clinical, regulatory, and quality processes—vital areas for biotech companies striving to bring innovative therapies to market.
Accelerating Growth and Efficiency
Veeva Basics allows biotech firms to streamline operations and reduce costs significantly. By providing
standardized applications, these companies can get operational with
industry-leading software in a matter of weeks. This transition marks a shift from disparate entry tools to comprehensive, top-tier solutions that facilitate scalability as firms expand.
Tailored Solutions for Unique Needs
Veeva Basics is particularly designed for fast-growing businesses, offering pre-configured and pre-validated solutions. This feature ensures rapid deployment, regardless of company size. Among its offerings are:
- - Veeva CTMS Basics: This tool facilitates effective management of clinical trials, encompassing milestones, monitoring, registration, problem-solving, and site communication.
- - Veeva Submissions Publishing Basics: This system aids in the creation, publication, and submission of regulatory applications from a single platform.
According to
Steve Harper, the General Manager of Veeva Basics, the adoption of these solutions is bridging a gap in availability. “An increasing number of biotechs are enjoying the time, cost, and effort savings that Veeva Basics provides in North America and Europe,” he notes.
Real-world Impact and Testimonials
The feedback from industry insiders underscores the transformative power of Veeva Basics. Dr.
Ian Hodgson, COO at
Corbus Pharmaceuticals, hailed its significance, stating, “Veeva Basics represents a turning point as it enables smaller biotech firms to access modern, connected applications that were previously exclusive to larger players.” His company is in growth mode, and he expresses confidence in Veeva's ability to scale alongside them.
Joe Thornton, Associate Director of Clinical Operations at
Scancell, shares, “As we expand our studies, Veeva eTMF Basics gives us greater control over our data and processes to ensure readiness for trials. Having a leading industry solution with pre-configured best practices will foster speed and innovation as we continue developing new immunotherapies.”
Moreover,
Dr. Rebecca Deng, Associate Director of Regulatory Affairs and Quality Systems at
Terns Pharmaceuticals, emphasizes the benefits of global support and training offered with Veeva Basics, noting how easily it leads to significant time and resource savings due to its straightforward deployment and validation processes.
The Future of Veeva Basics
Launched on the robust
Vault platform, Veeva Basics applications facilitate the scaling of clients’ technological infrastructure in tandem with their growth. As of now, both Veeva CTMS Basics and Submissions Publishing Basics are available in North America and Europe.
For those interested in learning more about how Veeva Basics can revolutionize their operations, detailed information is available at
veeva.com/VeevaBasics.
About Veeva Systems
Veeva is a leading provider of cloud software for the life sciences industry, committed to innovation, product quality, and customer success, serving over
1,000 customers ranging from the largest biopharmaceutical companies to emerging biotech firms. As a public benefit corporation, Veeva strives to balance the interests of all stakeholders involved, including customers, employees, shareholders, and the industries in which it operates.
For further inquiries, contact
Jeremy Whittaker at Veeva Systems or refer to
veeva.com/eu.